Don’t Miss TipRanks’ Half Year Sale
- Take advantage of TipRanks Premium for 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Haleon PLC Sponsored ADR ( (HLN) ) has provided an announcement.
On June 26, 2025, Haleon PLC announced the completion of the first tranche of its share buyback program, initially announced on March 28, 2025. The company repurchased 51,036,522 shares for approximately £200 million, all of which were canceled. This move is part of Haleon’s strategy to optimize its capital structure and potentially enhance shareholder value. The completion of this tranche may impact the company’s market positioning by reducing the number of shares with voting rights, which now stands at 8,984,453,348.
The most recent analyst rating on (HLN) stock is a Buy with a $13.40 price target. To see the full list of analyst forecasts on Haleon PLC Sponsored ADR stock, see the HLN Stock Forecast page.
Spark’s Take on HLN Stock
According to Spark, TipRanks’ AI Analyst, HLN is a Outperform.
Haleon’s strong financial performance, characterized by robust cash flow and stable profitability, is a key strength, complemented by positive technical indicators suggesting upward momentum. However, the stock’s valuation appears high, and recent earnings call highlights both opportunities in emerging markets and challenges like FX headwinds and product performance issues. These factors collectively position the stock at a solid yet cautious 73.1 score.
To see Spark’s full report on HLN stock, click here.
More about Haleon PLC Sponsored ADR
Haleon PLC is a global leader in consumer health, focusing on delivering better everyday health with humanity. The company’s product portfolio includes Oral Health, Vitamins, Minerals and Supplements, Pain Relief, Respiratory Health, Digestive Health, and Therapeutic Skin Health. Haleon is known for its trusted brands such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu, and Voltaren.
Average Trading Volume: 16,278,085
Technical Sentiment Signal: Buy
Current Market Cap: $47.17B
Find detailed analytics on HLN stock on TipRanks’ Stock Analysis page.